Introduction:Treating difficult non-unions with the Ilizarov technique has been the gold standard method for the last few decades. Here we have used Ilizarov for treating complex tibial fractures. The temporary management of compound fractures of the tibial diaphysis is commonly done with provisional external fixators which is followed by internal fixation. Ilizarov can also be used as a definitive fixation method besides it is more superior and can be the primary and definite choice of fixation where expertise is available. Materials and Methods: This was a prospective study conducted between august 2020 to august 2021 were 30 patients participated. Patients with complex tibial shaft fractures willing for regular follow up and surgical procedure were part of this study. All 30 0articipants were assessed for fracture union radiological and clinically using ASAMI functional and radiological score. The patients were evaluated at regular intervals until fracture union is observed. Results: From total of 30 patients 90% (26 patients) of fracture healed after Ilizarov ring fixation. The frame removed on an average of 177 days from the point of original injury. The healing time of closed fractures was a mean of 164 days. The open fracture healed in a mean time of 212 days. We encountered non-union in 4 patients after primary fixation. All the 4 cases were high velocity injury, classified under 42C2 or 42C3. All the 4 cases were open fractures. Conclusion: Ilizarov ring fixation is a versatile management option for the management of complex tibial diaphyseal fracture which also helps to manage and correct limb length discrepancies, correction of deformity in sagittal and coronal plane, along with managing fracture with bone gap and bone loss.
Introduction: De Quervains disease is a chronic inflammation of tendons of abductor pollicis longus (APL) and the extensor pollicis brevis (EPB) as they pass through 1 st dorsal extensor compartment of wrist. Aim of the study is to compare the functional outcome between PRP (Platelet rich plasma) vs Steroid injections in the management of this pathology. Methods: This was a prospective study of 30 patients with de quervains tenosynovitis and study conducted between September 2021 to November 2021 for a period of 3 months follow up done. The present study included 30 patients of both sexes, different age groups associated with co-morbidities divided into two groups. Group I received CS injection, and group II received PRP injection. Results: The average age of patients in Category I was 37 years and in category II was 37 years. A statistical difference was seen in VAS on comparing the baseline evaluation with the results after 1 month of injection administration. It was found that there was more depletion in VAS score in Category I (2.33%) after one month of injection whereas Category II showed an initial low depletion rate after one month (2.86%) followed by a steady decline rate after 3 months. A similar difference was reflected on using the Quick DASH score in which Category I projected a greater improvement after one month of injection use whereas Category II projected a steady improvement rate after 3 months of injection use. Conclusion: PRP for De Quervains tenosynovitis can be used as a 2nd line of management instead of steroid as PRP has better functional outcome and lesser complications as compared to steroid therapy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.